Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).

about

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).

Item

http://www.wikidata.org/entity/Q38881581

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Repeated measures analyses of ...... vs placebo (N06C4 [alliance]).

@en

type

Item

label

Repeated measures analyses of ...... vs placebo (N06C4 [alliance]).

@en

prefLabel

Repeated measures analyses of ...... vs placebo (N06C4 [alliance]).

@en

P1476

Repeated measures analyses of ...... vs placebo (N06C4 [alliance])

@en

P2093

Brandon J Birckhead

http://www.w3.org/2001/XMLSchema#string

Charles L Loprinzi

http://www.w3.org/2001/XMLSchema#string

David J Schwartz

http://www.w3.org/2001/XMLSchema#string

Drew K Seisler

http://www.w3.org/2001/XMLSchema#string

James A Martenson

http://www.w3.org/2001/XMLSchema#string

James D Bearden

http://www.w3.org/2001/XMLSchema#string

Jeff A Sloan

http://www.w3.org/2001/XMLSchema#string

Jon C Anders

http://www.w3.org/2001/XMLSchema#string

Michelle A Neben Wittich

http://www.w3.org/2001/XMLSchema#string

Pamela J Atherton

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence-based skin care management in radiation therapy: clinical update

Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial.

Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4

Assessment of breast aesthetics

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).

Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).

The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).

P2888

s00520-016-3213-3

P304

3847-3855

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-016-3213-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert C. Miller

P577

2016-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27075674

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

P932

4967382

http://www.w3.org/2001/XMLSchema#string